GERD
203
24
29
109
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
24 trials with published results (12%)
Research Maturity
109 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.9%
20 terminated out of 203 trials
84.5%
-2.1% vs benchmark
19%
38 trials in Phase 3/4
22%
24 of 109 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 109 completed trials
Clinical Trials (203)
Endoscopic Band Ligation for Treating Reflux Disease
Multicenter Single-Blind RCT of CTIF Versus LNF For Treatment of GERD in Patients Requiring Hiatal Hernia Repair
Thread-Embedding Acupuncture as an Adjunct to Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease
Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy
Antireflux Surgery Without Preoperative Esophageal Manometry
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
PROPER-GERD: A Prospective Crossover Study to Evaluate Probe Placement Optimization for Reflux Testing in Women and Lower-BMI Patients
Alginate vs Sucralfate for GERD Symptomatic Relief
The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
Pre- and Post-Therapy Evaluation of Air-Associated Symptoms in Patients With Gastro-esophageal Reflux Disease (GERD): Assessing the Role of Speech and Language Therapy
Effect of Obesity on Proton Pump Inhibitors
Famotidine and Antacids for Treatment of Dyspepsia
EndoStim Patient Registry
Transoral Incisional Fundoplication (TIF) for Patients Suffering From Gastroesophageal Reflux Disease in an Asian Population
Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM
Diaphragmatic Training on GERD
PRospective Registry of Esophageal Motility
Compassionate Use of Domperidone for Refractory Gastroparesis
A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks